Acadia Pharmaceuticals buy BMO Capital Markets
Start price
27.06.24
/
50%
€15.27
Target price
27.06.25
€28.91
Performance (%)
-8.09%
Price
15.08.24
€14.04
Summary
This prediction is currently active. With a performance of -8.09%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 27.06.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 1.226% | 1.226% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $31.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat